Search results for: 'future+of+logistics'

In this research deliverable, Frost & Sullivan’s senior analyst team across the healthcare sector provide bold perspectives and predictions for the industry in 2015. The markets covered include pharmaceuticals and biotech, medical devices, medical imaging, and healthcare IT, amongst others. The analysis captures the impact of trends which are expec...

23 Jun 2016  |  North America  |  Market Research

Growth Opportunities in the US Point-of-care Testing Market

Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

Infographics

×

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...

The research service provides an overview of the application of radio frequency identification (RFID) in the healthcare industry. It specifically focuses on RFID smart cabinet systems that track equipment and medical supplies in a healthcare environment. The study aims to analyse the technological advancements in RFID smart cabinet systems and incl...

This research service gives an overview of the healthcare technology trends in the BRIC nations. BRIC, that is, Brazil, Russia, India, and China are among the fastest-growing economies in the world now but the healthcare system in these countries are facing numerous challenges. One of the major issue is that the countries have been burdened with a ...

15 Jul 2024  |  Global  |  Technology Research

Connected Diabetes Care: Innovations and Growth Opportunities

Continuous Glucose Monitoring, Artificial Pancreas Systems, and Novel Insulin Delivery Formulations to Transform the Future of Diabetes Management

Infographics

×

The preference for diabetes self-assessment using wearable CGMs instead of finger-stick blood sugar testing is increasing, especially in type 1 diabetics (T1D). HbA1c and time-in-range are currently the preferred biomarkers for diabetes monitoring applications. Emerging diet and fitness tracking apps help support general well-being and prevent the ...

22 Apr 2022  |  Global  |  Market Research

Global Deep Brain Stimulation Growth Opportunities

Exploration of New Clinical Applications Drive Future Growth Potential

Infographics

×

Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity. This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently contribute...

21 Aug 2018  |  Global  |  Market Research

Artificial Intelligence for Medical Image Analysis—Companies-to-Action, 2018

Lay of the Land, Growth Opportunities and Future Direction

Infographics

×

Key Issues Addressed

Medical imaging has become the bellwether application for artificial intelligence (AI) technologies in healthcare. From deep learning and machine learning approaches, to cognitive computing, to even natural language processing, several AI approaches are now being incorporated in the field of radiology. Apart from academic research groups, almost al...

Interventional radiology is a specialized field of radiology for interpreting images while performing minimally invasive surgery. As the minimally invasive procedures are less expensive, less painful, and low risk than traditional surgeries, interventional radiology is gaining a lot of importance. Interventional radiology advances are primarily dir...

08 Jun 2022  |  North America  |  Market Research

Growth Opportunities in Sterile Injectable Outsourcing

Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

Infographics

×

Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...